Social Support Intervention Helps Those Living With HIV/AIDS

This article originally appeared here.
Share this content:
Social Support Intervention Helps Those Living With HIV/AIDS
Social Support Intervention Helps Those Living With HIV/AIDS

FRIDAY, Sept. 23, 2016 (HealthDay News) -- A social support intervention can improve social support and quality of life (QOL) for individuals living with HIV/AIDS, according to a study published online Sept. 20 in the Journal of Clinical Nursing.

Xing-ming Li, Ph.D., from Capital Medical University in Beijing, and colleagues conducted a nonrandomized controlled community intervention study involving participants diagnosed as People Living with HIV/AIDs. From December 2013 to December 2014, participants received comprehensive social support care.

The researchers found that for social support there were significant differences in the score of objective support and usage of support (all P = 0.02). After the intervention, net values of objective support score and usage of support were 0.25 and 0.19, respectively. Psychological function, role physical, general health, vitality, social function, mental health, health transition, and total QOL score all differed significantly (all P < 0.05). In canonical correlation analysis of net values of social support and QOL, statistically significant correlations were seen for the first and second canonical correlation (coefficients of 0.53 and 0.21, respectively).

"Social support and care intervention model can effectively improve perceived subjective feeling on social support and QOL condition for People Living with HIV/AIDS," the authors write. "And strategies to improve social support and care intervention programs are strongly encouraged."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »